Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Cost of Revenue (2016 - 2025)

Conmed (CNMD) has disclosed Cost of Revenue for 11 consecutive years, with $117.3 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Cost of Revenue fell 4.54% year-over-year to $117.3 million, compared with a TTM value of $402.2 million through Dec 2020, down 6.56%, and an annual FY2025 reading of $624.2 million, up 8.76% over the prior year.
  • Cost of Revenue was $117.3 million for Q4 2020 at Conmed, up from $104.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $122.9 million in Q4 2019 and bottomed at $83.5 million in Q1 2016.
  • Average Cost of Revenue over 5 years is $97.2 million, with a median of $95.7 million recorded in 2018.
  • The sharpest move saw Cost of Revenue grew 12.87% in 2019, then fell 19.82% in 2020.
  • Year by year, Cost of Revenue stood at $97.1 million in 2016, then grew by 1.51% to $98.6 million in 2017, then grew by 11.35% to $109.8 million in 2018, then rose by 11.93% to $122.9 million in 2019, then decreased by 4.54% to $117.3 million in 2020.
  • Business Quant data shows Cost of Revenue for CNMD at $117.3 million in Q4 2020, $104.1 million in Q3 2020, and $85.9 million in Q2 2020.